Electrocardiographic presentation of blacks with first myocardial infarction does not explain race differences in thrombolysis administration

American Heart Journal

Volumn 140, Issue 2, 2000, Pages 200-205

  Manhapra, Ajay ^a,b   Khaja, Fareed ^a,b   Syed, Mushabbar ^a,b   Rybicki, Benjamin A ^a,b   Wulbrecht, Nancy ^a,b   Alam, Mohsin ^a,b   Sabbah, Hani ^a,b   Goldstein, Sidney ^a,b   Borzak, Steven ^a,b  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; ETHNIC GROUP; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033897363     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.107173     Document Type: Article

References (25)

1. Decline in the rate of hospital mortality from acute myocardial infarction: Impact of changing management strategies
2. A 2-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: A community-wide perspective
3. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction
4. Lower thrombolytic use for African Americans with myocardial infarction: An influence of clinical presentation?
5. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992
6. Management and outcomes for black patients with acute myocardial infarction in the reperfusion era: National Registry of Myocardial Infarction 2 Investigators
7. Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states
8. Understanding racial differences in the use of thrombolytic therapy: What more do we need to know?
9. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
10. Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial
11. Coronary heart disease mortality/morbidity and risk in blacks, I: Clinical manifestations and diagnostic criteria: The experience with the Beta Blocker Heart Attack Trial
12. Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart Study
13. Electrocardiographic findings in a healthy biracial population: Atherosclerosis Risk in Communities (ARIC) Study Investigators
14. Acute myocardial infarction: Clinical characteristics, management and outcome in a metropolitan Veterans Affairs Medical Center teaching hospital
15. 'Inadvertent' thrombolytic administration in patients without myocardial infarction: Clinical features and outcome
16. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2
17. Quality of care for Medicare patients with acute myocardial infarction: A 4-state pilot study from the Cooperative Cardiovascular Project
18. Effect of delay on racial differences in thrombolysis for acute myocardial infarction
19. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: Results from The TIMI II Study
20. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: Angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy: GUSTO-I Angiographic Investigators
21. Q wave and non-Q wave myocardial infarction after thrombolysis
22. Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)
23. Effect of race on the presentation and management of patients with acute chest pain
24. Lower rate of reperfusion therapy in African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics
25. The effect of race and sex on physicians' recommendations for cardiac catheterization